Subcutaneous administration of midazolam in pediatric diagnostic procedures
Phase 2
Recruiting
- Conditions
- sedation during procedure.
- Registration Number
- IRCT20171030037093N20
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria
The age range of over three months up to five years
Children requiring diagnostic procedures such as CT scan
Exclusion Criteria
The patients with excessive sensitivity to Benzodiazepines
Medical disorder of shock or blood pressure
Alcohol intoxication
Poor vital signs
Pulmonary diseases
Myasthenia gravis or musculoskeletal disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The length of the sedative effect. Timepoint: From the beginning of sedation to the return of the child to full consciousness. Method of measurement: Computing.
- Secondary Outcome Measures
Name Time Method